News | June 03, 2009

Naviscan Licenses Biopsy-Guidance Accessory

June 2, 2009 - Naviscan Inc. has issued a nonexclusive licensing agreement with an undisclosed imaging company for intellectual property that enables Naviscan’s Stereo Navigator PEM-guided biopsy accessory to obtain emission data, locate the abnormal tissue and process the data to guide a biopsy needle.

This is the second licensing agreement based on Naviscan’s intellectual property portfolio, reinforces Naviscan’s leadership position in molecular breast imaging (MBI). The company is currently negotiating licensing agreements with other diagnostic imaging companies and expects these agreements to be signed as early as the third quarter of 2009.

The new licensing agreement covers the use of Stereo Navigator, a medical method and apparatus for the localization and biopsy of lesions. This patent enables PET scanners and gamma cameras to obtain emission data, locate the abnormal tissue and process the data to best guide a biopsy needle to acquire a sample of the abnormal tissue. The previous licensing agreement concerned a method and apparatus patent enabling the immobilization and compression of a body part for the purposes of collecting PET or gamma emission data in an effort to create a physiological image of the body part.

Naviscan currently has four other patents pending.

Naviscan was recently awarded Frost & Sullivan’s 2009 “Emerging Technology of the Year.”

For more information: www.naviscan.com

Related Content

Synergy Radiology Associates Employs UroNav Fusion Biopsy System for Better Prostate Cancer Diagnosis
News | Biopsy Systems | July 17, 2017
Radiologists from Synergy Radiology Associates (SRA) in Houston are using the power of 3-D medical imaging and...
Analogic, bkFusion, bk3000, MRI-ultrasound fusion, prostate biopsy, EAU 2017
News | Biopsy Systems | March 30, 2017
March 30, 2017 — Analogic Corp.
Karmanos Cancer Institute, UroNav Fusion Biopsy System, prostate cancer
News | Biopsy Systems | March 23, 2017
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroN
Exact Imaging, Health Canada approval, ExactVu micro-ultrasound system, prostate biopsies, Sunnybrook Health Sciences Centre, Gregory Czarnota
News | Biopsy Systems | March 16, 2017
March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#986
MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016
Technology | Fusion Imaging Software | January 03, 2017
MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate...
News | Biopsy Systems | August 25, 2016
Dune Medical Devices has been selected as one of the few recipients of a European Union Horizon 2020 research grant to...
News | X-Ray | August 12, 2016
August 10,  2016 —Kubtec is helping with with an anthropologic imaging study of dried fetal skulls. 
lung cancer, nonsolid nodules, NSNs, CT scan follow-up, computed tomography, Claudia Henschke
News | Lung Cancer | July 18, 2016
Annual low-dose computed-tomography (CT) screening can eliminate the need for biopsy or surgery in nonsolid lung...
prostate cancer, biopsy, PET-CT, Ga-68 PSMA, SNMMI 2016 study, Wolfgang Fendler
News | PET-CT | June 20, 2016
Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of...
UAB, iSR'obot Mona Lisa, prostate cancer, image-guided biopsy

Jeffrey Nix, M.D., left, and Soroush Rais-Bahrami, M.D., with the iSR’obotTM Mona Lisa , a new image guided device for diagnosing prostate cancer. Image courtesy of UAB News.

News | Biopsy Systems | June 09, 2016
The University of Alabama at Birmingham (UAB) announced it is one of two beta sites in the United States that will...
Overlay Init